1. Home
  2. MD vs CGON Comparison

MD vs CGON Comparison

Compare MD & CGON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MD
  • CGON
  • Stock Information
  • Founded
  • MD 1979
  • CGON 2010
  • Country
  • MD United States
  • CGON United States
  • Employees
  • MD N/A
  • CGON N/A
  • Industry
  • MD Hospital/Nursing Management
  • CGON
  • Sector
  • MD Health Care
  • CGON
  • Exchange
  • MD Nasdaq
  • CGON NYSE
  • Market Cap
  • MD 1.2B
  • CGON 1.3B
  • IPO Year
  • MD 1995
  • CGON 2024
  • Fundamental
  • Price
  • MD $13.02
  • CGON $21.04
  • Analyst Decision
  • MD Buy
  • CGON Strong Buy
  • Analyst Count
  • MD 6
  • CGON 10
  • Target Price
  • MD $16.75
  • CGON $65.11
  • AVG Volume (30 Days)
  • MD 729.0K
  • CGON 1.3M
  • Earning Date
  • MD 05-06-2025
  • CGON 05-08-2025
  • Dividend Yield
  • MD N/A
  • CGON N/A
  • EPS Growth
  • MD N/A
  • CGON N/A
  • EPS
  • MD N/A
  • CGON N/A
  • Revenue
  • MD $2,012,919,000.00
  • CGON $1,139,000.00
  • Revenue This Year
  • MD N/A
  • CGON N/A
  • Revenue Next Year
  • MD $2.76
  • CGON $16,237.24
  • P/E Ratio
  • MD N/A
  • CGON N/A
  • Revenue Growth
  • MD 0.92
  • CGON 461.08
  • 52 Week Low
  • MD $6.62
  • CGON $14.80
  • 52 Week High
  • MD $17.67
  • CGON $46.99
  • Technical
  • Relative Strength Index (RSI)
  • MD 39.45
  • CGON 43.36
  • Support Level
  • MD $12.96
  • CGON $19.47
  • Resistance Level
  • MD $13.60
  • CGON $20.63
  • Average True Range (ATR)
  • MD 0.61
  • CGON 2.04
  • MACD
  • MD -0.09
  • CGON 0.20
  • Stochastic Oscillator
  • MD 14.66
  • CGON 48.54

About MD Pediatrix Medical Group Inc.

Pediatrix Medical Group Inc provides physician services to hospitals, intensive care units, and other medical units. The services provided by the company include maternal care for expectant mothers, intensive care for premature babies, cardiology care for infants suffering from heart defects, and anesthesia care during surgeries, among others. The company operates only under one segment which provides physician services including newborn, maternal-fetal, and other pediatric subspecialty care. It generates majority of the revenue through neonatology and other pediatric subspecialties.

About CGON CG ONCOLOGY INC

CG Oncology Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. The company's lead candidate, cretostimogene grenadenorepvec, is a targeted oncolytic intravesically delivered immunotherapy agent that is in two phase three trials (one high-risk BCG unresponsive NMIBC trial and one intermediate-risk NMIBC trial) and a phase two clinical study with a checkpoint inhibitor for high-risk BCG unresponsive NMIBC disease.

Share on Social Networks: